keyword
https://read.qxmd.com/read/24920900/liposomes-versus-metallic-nanostructures-differences-in-the-process-of-knowledge-translation-in-cancer
#21
COMPARATIVE STUDY
David Fajardo-Ortiz, Luis Duran, Laura Moreno, Héctor Ochoa, Víctor M Castaño
This research maps the knowledge translation process for two different types of nanotechnologies applied to cancer: liposomes and metallic nanostructures (MNs). We performed a structural analysis of citation networks and text mining supported in controlled vocabularies. In the case of liposomes, our results identify subnetworks (invisible colleges) associated with different therapeutic strategies: nanopharmacology, hyperthermia, and gene therapy. Only in the pharmacological strategy was an organized knowledge translation process identified, which, however, is monopolized by the liposomal doxorubicins...
2014: International Journal of Nanomedicine
https://read.qxmd.com/read/24598376/potentials-and-emerging-trends-in-nanopharmacology
#22
REVIEW
Keerti Jain, Neelesh Kumar Mehra, Narendra Kumar Jain
Nanopharmacology is a relatively newer branch of pharmacology which investigates interaction of a nanomedicine with living systems at the nanoscale level. Modern medicine is increasingly concerned with various surface modified nanocarriers, such as dendrimers, nanoparticles, carbon based nanomaterials, polymer-drug nanoconjugates, etc., which have immense therapeutic potential by target specific drug delivery, using nanoscaffolding and nanocontainers, owing to the specific physical, chemical and biological properties of these moieties that is related to their nanoscale size range...
April 2014: Current Opinion in Pharmacology
https://read.qxmd.com/read/24461938/blood-protein-coating-of-gold-nanoparticles-as-potential-tool-for-organ-targeting
#23
JOURNAL ARTICLE
Martin Schäffler, Fernanda Sousa, Alexander Wenk, Leopoldo Sitia, Stephanie Hirn, Carsten Schleh, Nadine Haberl, Martina Violatto, Mara Canovi, Patrizia Andreozzi, Mario Salmona, Paolo Bigini, Wolfgang G Kreyling, Silke Krol
Nanoparticles (NP) and nanoparticulated drug delivery promise to be the breakthrough for therapy in medicine but raise concerns in terms of nanotoxicity. We present quantitative murine biokinetics assays using polyelectrolyte-multilayer-coated gold NP (AuNP, core diameter 15 and 80 nm; (198)Au radio-labeled). Those were stably conjugated either with human serum albumin (alb-AuNP) or apolipoprotein E (apoE-AuNP), prior to intravenous injection. We compare the biokinetics of protein-AuNP-conjugates with citrate-stabilized AuNP (cit-AuNP)...
March 2014: Biomaterials
https://read.qxmd.com/read/23631284/-problems-of-toxicity-of-nanopharmacological-preparations
#24
R D Seĭfulla, E K Kim
No abstract text is available yet for this article.
2013: Eksperimental'naia i Klinicheskaia Farmakologiia
https://read.qxmd.com/read/23035596/-carbonology-pharmacochemical-aspect-and-and-research-prospects
#25
JOURNAL ARTICLE
(no author information available yet)
The paper is devoted to the new direction of science - carbonology. Carbon is the base of organic compounds. Compounds of carbon with metals are known. The article gives a brief description of the three allotropic forms of carbon (soot, graphite, diamond), and various types of hybridization in organic structures, describes the role of biogenic carbon. At the end of the twentieth century new carbon nanostructures were discovered: fullerenes and carbon nanotubes. Scientists all over the world study physical, chemical, pharmacological and toxicological properties of the allotropes of carbon structures, which are promising for nanochemistry, nanopharmacology and nanotoxicology...
January 2012: Likars'ka Sprava
https://read.qxmd.com/read/21254597/-drug-bioavailability-improvement-by-means-of-nanopharmacology-pharmacokinetics-of-liposomal-drugs
#26
REVIEW
A K Sariev, D A Abaimov, R D Seĭfulla
Modern approaches to increasing the efficiency of liposomal transport of substances are discussed. Examples of creating new nanopharmacological drugs that exceed the pharmacokinetic characteristic of their classical analogs are given.
November 2010: Eksperimental'naia i Klinicheskaia Farmakologiia
https://read.qxmd.com/read/21224780/emergency-endovascular-nanopharmacologic-treatment-in-advanced-gynecological-cancers
#27
JOURNAL ARTICLE
Andrea Tinelli, Raffaele Prudenzano, Antonio Malvasi, Mario Santantonio, Vito Lorusso
INTRODUCTION: Advanced cases of uterine carcinomas with parametrial and fornix infiltration often cause massive genital bleeding, with severe anemia, fast deterioration, and a high risk of death for patients; women with advanced uterine cancer (UC) and genital massive bleeding were treated using an endovascular therapy in local anesthesia. METHODS: Ten women with advanced UC and genital massive bleeding were hospitalized for a high risk of immediate death; after blood transfusions and resuscitation therapy, the patients were submitted to an experimental nanopharmacologic endovascular therapy in local anesthesia...
October 2010: International Journal of Gynecological Cancer
https://read.qxmd.com/read/20957528/multidimensional-atomic-force-microscopy-a-versatile-novel-technology-for-nanopharmacology-research
#28
REVIEW
Ratnesh Lal, Srinivasan Ramachandran, Morton F Arnsdorf
Nanotechnology is giving us a glimpse into a nascent field of nanopharmacology that deals with pharmacological phenomena at molecular scale. This review presents our perspective on the use of scanning probe microscopy techniques with special emphasis to multidimensional atomic force microscopy (m-AFM) to explore this new field with a particular emphasis to define targets, design therapeutics, and track outcomes of molecular-scale pharmacological interactions. The approach will be to first discuss operating principles of m-AFM and provide representative examples of studies to understand human health and disease at the molecular level and then to address different strategies in defining target macromolecules, screening potential drug candidates, developing and characterizing of drug delivery systems, and monitoring target-drug interactions...
December 2010: AAPS Journal
https://read.qxmd.com/read/20874016/nanopharmacology-of-liposomes-developed-for-cancer-therapy
#29
EDITORIAL
Madaswamy S Muthu, Si-Shen Feng
No abstract text is available yet for this article.
September 2010: Nanomedicine
https://read.qxmd.com/read/20821980/-nanopharmacology-not-a-constituent-part-of-homeopathy
#30
COMPARATIVE STUDY
R D Seĭfulla
No abstract text is available yet for this article.
July 2010: Eksperimental'naia i Klinicheskaia Farmakologiia
https://read.qxmd.com/read/20420215/-nanomedicine-as-a-part-of-nanotechnology
#31
REVIEW
L B Piotrovskiĭ
In the general sense, nanomedicine is defined as the application of nanotechnologies including nanobiothechnologies in medicine. Under conditions of current rapid development of nanotechnologies, many terms and definitions lack clarity and precision and boundaries between traditional and nanotechnologies are equally poorly determined. Evidently, dimensional parameters alone are insufficient to refer someone or other work to the field of nanotechnology (e.g., nanomedicine). Fundamental novelty of nanomedicine as a branch of knowledge and technology is exemplified by the developments in pharmacology and design of medicinal products that brought about new nanomedical (nanopharmacological, nanopharmaceutical) drugs...
2010: Vestnik Rossiĭskoĭ Akademii Meditsinskikh Nauk
https://read.qxmd.com/read/20404619/nanopharmacology-for-the-future-think-small
#32
JOURNAL ARTICLE
Patricia O'Malley
No abstract text is available yet for this article.
May 2010: Clinical Nurse Specialist CNS
https://read.qxmd.com/read/19877425/-nanoparticles-properties-and-application-prospects
#33
REVIEW
I S Chekman
A new trend of scientific-technical and medical researches has been formed which unites nanoscience, nanotechnology, nanomedicine, nanopharmacology. Nanoparticles are the main product of nanotechnologies. Nanoparticles are organic and inorganic structures, their size being less than one hundred nanometers (nano from Greece nanos--a dwarf; particle is a separate unit which is separated from the whole). Prefix nano means 10(-9) m. Nanosizes are values from 1 to 100 nanometers, micro-sizes--from 100 to 1000 nanometers, and above 1000 nanometers--are macrosizes...
January 2009: Ukraïnsʹkyĭ Biokhimichnyĭ Z︠h︡urnal
https://read.qxmd.com/read/19145830/-nanopharmacology-experimental-and-clinic-aspect
#34
REVIEW
I S Chekman
The literature data and own investigations of the use of the nanotechnologies in medicine have been analyzed in the article. First investigations in the field of nanotechnology made the basis of new decisions in medicine, pharmacology, gene engineering and robot technology. Miniaturisation defines new chemical, physical and biological characteristics of biological objects, which differ from macroobject's characteristics. Study of this unique properties allows developing new technologies and methods in medicine...
April 2008: Likars'ka Sprava
https://read.qxmd.com/read/18069613/-nanotechnology-nanomedicine-and-nanopharmacology
#35
Pedro Lorenzo Fernández
Based on Nanotechnology methods, Nanomedicine and Nanotecnology will obtain significant advances in areas such as Diagnostic, Regenerative Medicine and pharmacological Therapeutics. With nanotechnology-based drug delivery systems,important improvement on pharmacokinetics of drugs will take place, due to increased solubility, protection against decrease in drug effects due to excessive metabolism and subsequent increase of bioavailability. Improvement on pharmacodynamic parameters will occur also due to increased drug concentration in target tissues...
2007: Anales de la Real Academia Nacional de Medicina
https://read.qxmd.com/read/16158070/nanoparticle-induced-platelet-aggregation-and-vascular-thrombosis
#36
COMPARATIVE STUDY
Anna Radomski, Paul Jurasz, David Alonso-Escolano, Magdalena Drews, Maria Morandi, Tadeusz Malinski, Marek W Radomski
Ever increasing use of engineered carbon nanoparticles in nanopharmacology for selective imaging, sensor or drug delivery systems has increased the potential for blood platelet-nanoparticle interactions. We studied the effects of engineered and combustion-derived carbon nanoparticles on human platelet aggregation in vitro and rat vascular thrombosis in vivo. Multiplewall (MWNT), singlewall (SWNT) nanotubes, C60 fullerenes (C60CS) and mixed carbon nanoparticles (MCN) (0.2-300 microg ml(-1)) were investigated...
November 2005: British Journal of Pharmacology
https://read.qxmd.com/read/12676041/controlled-clinical-trials-evaluating-the-homeopathic-treatment-of-people-with-human-immunodeficiency-virus-or-acquired-immune-deficiency-syndrome
#37
REVIEW
Dana Ullman
CONTEXT: Homeopathic medicine developed significant popularity in the nineteenth century in the United States and Europe as a result of its successes treating the infectious disease epidemics during that era. Homeopathic medicine is a medical system that is specifically oriented to using nanopharmacologic and ultramolecular doses of medicines to strengthen a person's immune and defense system rather than directly attacking the microbial agents. OBJECTIVES: To review the literature referenced in MEDLINE and in nonindexed homeopathic journals for placebo-controlled clinical trials using homeopathic medicines to treat people with AIDS or who are human immunodeficiency virus (HIV)-positive and to consider a different theoretical and methodological approach to treating people with the viral infection...
February 2003: Journal of Alternative and Complementary Medicine: Research on Paradigm, Practice, and Policy
1
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.